Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting

被引:24
作者
Bhargava, B [1 ]
Kornowski, R [1 ]
Mehran, R [1 ]
Kent, KM [1 ]
Hong, MK [1 ]
Lansky, AJ [1 ]
Waksman, R [1 ]
Pichard, AD [1 ]
Satler, LF [1 ]
Leon, MB [1 ]
机构
[1] Washington Hosp Ctr, Div Cardiol, Cardiac Catheterizat Lab, Washington, DC 20010 USA
关键词
D O I
10.1016/S0735-1097(99)00564-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We evaluated the early and mid-term (18-month) clinical events in a consecutive series of patients undergoing a nonstaged multiple saphenous vein grafting (SVG) intervention with stents as compared with a single SVG stent procedure. BACKGROUND Saphenous vein graft angioplasty has been limited by high rates of distal embolization, myocardial infarction, restenosis and late mortality. It is unknown whether stenting of multiple, different SVGs at the same setting is associated with higher risk. METHODS We evaluated in-hospital and mid-term clinical outcomes (death, Q wave myocardial infarction [MI] and repeat revascularization rates up to 18 months) in 70 consecutive patients treated with coronary stents in 2 (93% of patients) or 3 SVGs, as compared with 649 patients undergoing stenting of a single SVG between January 1, 1994 and December 31, 1997. RESULTS Overall procedural success was obtained in 97% of patients with 2 or 3 SVGs and 97% of patients with a single SVG (p = 0.94). Procedural complications were also similar (2.8% for multiple SVGs vs. 2.7% for a single SVG, p = 0.94). There was a higher prevalence of periprocedural non-Q wave MI (28% vs. 16%, p = 0.009) in the multiple SVG group. During follow-up (18 months), target lesion revascularization was 11% in multiple SVG and 15% in single SVG interventions (p = 0.19), and repeat revascularization (calculated per treated patient) was also similar for both groups (19% vs. 18%, p = 0.94). There was no difference in death (5.6% vs. 5.3%, p = 0.92) and Q wave MI rate (4.3% vs. 2.9%, p = 0.55) after the multiple SVG intervention. Overall cardiac event-free survival was similar for both groups (62% vs. 60%, p = 0.75). The study was powered to detect a clinically meaningful difference of 10% in mortality; smaller differences could not be evaluated on the basis of this sample size. CONCLUSIONS Simultaneous stenting of multiple SVGs in carefully selected patients has similar in-hospital procedural success and major complications rates, as well as mid-term (18-month) clinical outcomes, as compared with single SVG stenting. Thus, multiple SVG interventions using stents may be a viable revascularization strategy for carefully selected patients and suitable lesions in multiple SVG disease. (J Am Coll Cardiol 2000;35:389-97) (C) 2000 by the American College of Cardiology.
引用
收藏
页码:389 / 397
页数:9
相关论文
共 38 条
[1]  
BOURASSA MG, 1985, CIRCULATION, V72, P71
[2]  
BOURASSA MG, 1984, AM J CARDIOL, V53, P102
[3]   Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years [J].
Brener, SJ ;
Ellis, SG ;
AppersonHansen, C ;
Leon, MB ;
Topol, EJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (01) :13-18
[4]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[5]   Myonecrosis after revascularization procedures [J].
Califf, RM ;
Abdelmeguid, AE ;
Kuntz, RE ;
Popma, JJ ;
Davidson, CJ ;
Cohen, EA ;
Kleiman, NS ;
Mahaffey, KW ;
Topol, EJ ;
Pepine, CJ ;
Lipicky, RJ ;
Granger, CB ;
Harrington, RA ;
Tardiff, BE ;
Crenshaw, BS ;
Bauman, RP ;
Zuckerman, BD ;
Chaitman, BR ;
Bittl, JA ;
Ohman, EM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :241-251
[6]   THE RELATION OF RISK-FACTORS TO THE DEVELOPMENT OF ATHEROSCLEROSIS IN SAPHENOUS-VEIN BYPASS GRAFTS AND THE PROGRESSION OF DISEASE IN THE NATIVE CIRCULATION - A STUDY 10 YEARS AFTER AORTOCORONARY BYPASS-SURGERY [J].
CAMPEAU, L ;
ENJALBERT, M ;
LESPERANCE, J ;
BOURASSA, MG ;
KWITEROVICH, P ;
WACHOLDER, S ;
SNIDERMAN, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (21) :1329-1332
[7]  
DEFEYTER P, 1998, J AM COLL CARDIOL, V21, P1539
[8]   PERCUTANEOUS TRANS-LUMINAL ANGIOPLASTY OF A TOTALLY OCCLUDED VENOUS BYPASS GRAFT - A CHALLENGE THAT SHOULD BE RESISTED [J].
DEFEYTER, PJ ;
SERRUYS, P ;
VANDENBRAND, M ;
MEESTER, H ;
BEATT, K ;
SURYAPRANATA, H .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (01) :88-90
[9]   Long-term clinical outcome after stent implantation in saphenous vein grafts [J].
deJaegere, PP ;
vanDomburg, RT ;
deFeyter, PJ ;
Ruygrok, PN ;
vanderGiessen, WJ ;
vandenBrand, MJ ;
Serruys, PW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (01) :89-96
[10]   PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY IN PATIENTS WITH PRIOR CORONARY-BYPASS SURGERY [J].
DOUGLAS, JS ;
GRUENTZIG, AR ;
KING, SB ;
HOLLMAN, J ;
ISCHINGER, T ;
MEIER, B ;
CRAVER, JM ;
JONES, EL ;
WALLER, JL ;
BONE, DK ;
GUYTON, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 2 (04) :745-754